Skip to main content

Advertisement

Open Peer Review Reports for: Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
6 Oct 2004 Submitted Original manuscript
29 Nov 2004 Reviewed Reviewer Report - Avi Ashkenazi
5 Dec 2004 Reviewed Reviewer Report - Alexandru Almasan
9 Dec 2004 Author responded Author comments - Christina Voelkel-Johnson
Resubmission - Version 2
9 Dec 2004 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
1 Jan 2005 Reviewed Reviewer Report - Avi Ashkenazi
5 Jan 2005 Reviewed Reviewer Report - Alexandru Almasan
6 Jan 2005 Author responded Author comments - Christina Voelkel-Johnson
Resubmission - Version 4
6 Jan 2005 Submitted Manuscript version 4
Publishing
7 Jan 2005 Editorially accepted
7 Jan 2005 Article published 10.1186/1471-2407-5-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement